Explore Teva in Ireland
The chances are someone you know is living a healthier life because of our medicines; after all we are the largest
supplier of prescription medicines to Irish pharmacies. 01
Working together to help improve lives
Teva is proud to provide high-quality medicines that improve the health of people around the world, both prescription medications as well as over-the-counter treatments. We are continually expanding our range of products and services to better meet the needs of Irish patients and healthcare professionals.
Whilst you're reading this...
An Irish doctor is writing a prescription for a Teva medicine, to improve their patient’s outcome.
In a pharmacy right now...
An Irish pharmacist is reaching for a Teva product, secure in the knowledge that Teva medicines meet the highest standards for quality and safety.
And across town...
An Irish parent is trusting a Teva medicine to help a sick child get well.
We're a key partner to the Irish health service
Like all health systems globally, the Health Service Executive is under huge pressure from rising patient demand from an aging population, often managing multiple chronic conditions, and rising costs. At Teva we're working hard to help the HSE do more with less, by driving sustainability and value through our wide range of generic medicines and innovative medicines.
Working closely with healthcare organisations
We’re focused on improving how long-term conditions are managed, addressing cost-efficient prescribing and ensuring high quality joined-up care for the patient.
Innovating for future healthcare needs
We're also looking at healthcare options that are fit for the future, like new technologies, innovative devices, and a fresh approach to services.
Investing in Ireland
Teva is a major employer in Ireland with hundreds of highly skilled colleagues working in our research and manufacturing facilities.
Teva employs around 800 people across three sites in the Republic of Ireland and we have one site in Northern Ireland focused on research.
Teva supplies more prescription medicines than anyone else*
Teva is one of the largest suppliers of medicines in Ireland 01 and the team that work hard to keep the supply of medicines moving around Ireland are based in Swords, Dublin.
They are supported by a team of dedicated Teva representatives working with pharmacies and hospitals to ensure medicines are available to the patients that need them.
Supporting the supply of our medicines
Our commercial activities span the sales and support services for Teva’s large portfolio of medicines, both generics and branded innovative medicines, along with over-the-counter consumer health products.
Offering choice and value
We supply medicines to treat a wide range of diseases and conditions – from multiple sclerosis, migraine and asthma, to pain relief, cholesterol reducers and antibiotics.
Our dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions and inhalers.
Dedicated to helping patients
This is Paul, a District Key Account Executive in the Retail Sales Team.
"I’ve worked in the Irish pharmaceutical industry for 35 years and it’s great being a small part of the medical care system that is providing hope and relief to patients on our medicines."Read more
Teva's generic medicines save millions of Euros for the health service
Many of our medicines are 'generic'. Generic medicines contain the same active, or key, ingredient as the original medicine brand. Generic medicines are typically sold at a substantially lower price compared to their branded medicine counterparts, as the development process is generally less costly.
Teva is one of the largest suppliers of generic medicines in Ireland. 01
Making greater use of generic medicines
In 2013, Ireland introduced compulsory generic medicines substitution into the country, this led to a big change in medicine usage in Ireland – away from branded medicines to more affordable, but equally effective generic medicines. Five years later, the real economic benefit of that initiative became evident.
In 2013 the proportion of generic medicines dispensed was low, at just 11% but that figure rose to 58% in 2018, following the introduction of this legislation.02
Improving the affordability of medicines
The average price per pack of medicines has fallen from €18 in 2013, down to €6 in 2018 - that's a decrease of €12 per pack of medicine. 02
Driving savings to enable investment in other vital services
The benefits to the healthcare system and the Exchequer, and ultimately for patients are remarkable: An estimated €1.6 billion in medicine savings were counted between 2013 and 2018, solely from substituting branded medicines for an interchangeable, equally effective, generic medicines. 02
Using less expensive, high-quality generic medicines frees up valuable funds and enables them to be redirected to where patients urgently need them.
Playing our part
As one of Ireland’s largest suppliers of generic medicines, Teva is contributing significantly to the savings made by switching to better value, unbranded medicines.
In fact, one in eight prescription packs supplied to Irish pharmacies is a Teva pack. 03
A jewel in the Emerald Isle
Our Waterford site is dedicated to the manufacture and development of respiratory products, mainly for supply to the United States and around 30 other countries. It includes an onsite research and development centre which is dedicated to the next generation of respiratory products for the treatment of conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD).
Breathing life into respiratory medicines
Ireland is an important manufacturing hub for Teva’s respiratory medicines supplying healthcare services and patients all around the world.
Our teams there are experts in manufacturing both the medicine and the device, including multidose dry-powder inhalers, metered dose inhalers and e-connected inhalers for asthma and COPD.
Uncompromising dedication to quality
The Waterford site quality standards are recognised as the gold standard within Teva. The site is FDA approved (which means we are approved to export our products to the US, by United States' Food and Drug Administration), along with the European Medicines Agency and multiple local regulators.
All of our manufacturing processes are validated and products are tested and certified, using state-of-the-art testing equipment throughout the manufacturing process - that ensures adherence to the highest quality and compliance standards.
Innovating in respiratory medicine and devices
At our Waterford site we make ‘smart’ digi-halers which connect with your smartphone to record data which can be analysed to inform patients and physicians about the device usage.
Using smart inhaler technology patients may be empowered to manage their condition more effectively, and healthcare professionals could get greater insight into the patient's experience and condition to make more informed treatment decisions.
Passionate about improving patients' lives
This is Andy, the General Manager at Teva’s Respiratory Site in Waterford, Ireland.
"My wish is to grow into an even bigger site, producing a broader and more complex range of respiratory products and helping patients all over the world to breathe more easily."Read more
Soothing skin irritations in Ireland and beyond
Our over-the-counter medication Sudocrem® was first developed in 1931 in Dublin, and is now a multi-award winning, globally recognised product sold in over 50 countries.
Sudocrem® Antiseptic Healing Cream is an absolute staple in Irish households, loved by Irish families for its ability to soothe cuts, grazes, bed sores, sunburn, eczema as well as nappy rash. We're really proud that Sudocrem® is the top selling nappy rash product in 15 countries.
Soothing your family’s skin for 90 years
Developed in 1931 to treat nappy rash by Dublin pharmacist Thomas Smith, the classic formula has remained unchanged since then.
Positively Impacting Ireland's Economy
As an employer and a manufacturer, Teva creates jobs and contributes to economic output. Beyond direct expenditures, Teva's spending initiates a series of income creation, spending and re-spending that support other jobs and contribute to additional Gross Domestic Product (GDP).
Contributing beyond medicines
Teva's economic impact in 2018 included supporting more than 1,200 full-time jobs, contributing €351 million to GDP and generating €68 million in labour income, a measure of aggregate worker wages. 04
We are dedicated to helping to improve the health of generations of Teva patients in Ireland for years to come.
Back to contents.
Teva Ireland – Data on file
Back to contents.
Medicines for Ireland https://www.medicinesforireland.ie/wp content/uploads/2017/06/Medicines_for_Ireland-Generics@5.pdf - Accessed June 2021
Back to contents.
Teva Ireland – Data on file
Back to contents.
Teva Economic Impact Report - Matrix Global Advisors estimate of Teva’s Macroeconomic Impact in Ireland in 2018